BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7579002)

  • 1. New approaches for treatment in diabetes: aldose reductase inhibitors.
    Hotta N
    Biomed Pharmacother; 1995; 49(5):232-43. PubMed ID: 7579002
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy.
    Florkowski CM
    Med J Aust; 1993 Nov; 159(10):711-2. PubMed ID: 8110237
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy.
    Yue DK; Brooks B
    Med J Aust; 1993 Jul; 159(2):76-8. PubMed ID: 8336605
    [No Abstract]   [Full Text] [Related]  

  • 4. Three-year inhibition of aldose reductase on development of symptomatic neuropathy in diabetic patients.
    Baba M; Kimura K; Suda T; Yagihashi S;
    J Peripher Nerv Syst; 2006 Jun; 11(2):176-8. PubMed ID: 16787519
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of aldose reductase inhibitors in diabetic complications: recent trends.
    Kaul CL; Ramarao P
    Methods Find Exp Clin Pharmacol; 2001 Oct; 23(8):465-75. PubMed ID: 11838322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy.
    Wright M; Hill S; Slaney MA
    Med J Aust; 1994 Jan; 160(1):45. PubMed ID: 8123141
    [No Abstract]   [Full Text] [Related]  

  • 7. Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites.
    El-Kabbani O; Wilson DK; Petrash M; Quiocho FA
    Mol Vis; 1998 Sep; 4():19. PubMed ID: 9756955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldose reductase inhibitors and the complications of diabetes mellitus.
    Tomlinson DR
    Diabet Med; 1993 Apr; 10(3):214-30. PubMed ID: 8485953
    [No Abstract]   [Full Text] [Related]  

  • 9. Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage.
    Greene DA; Sima AA; Stevens MJ; Feldman EL; Killen PD; Henry DN; Thomas T; Dananberg J; Lattimer SA
    Diabetes Metab Rev; 1993 Oct; 9(3):189-217. PubMed ID: 8187607
    [No Abstract]   [Full Text] [Related]  

  • 10. Aldose reductase inhibitors and diabetic complications.
    Raskin P; Rosenstock J
    Am J Med; 1987 Aug; 83(2):298-306. PubMed ID: 3113248
    [No Abstract]   [Full Text] [Related]  

  • 11. Aldose reductase inhibitors and their potential for the treatment of diabetic complications.
    Tomlinson DR; Stevens EJ; Diemel LT
    Trends Pharmacol Sci; 1994 Aug; 15(8):293-7. PubMed ID: 7940997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldose reductase and its inhibition in the control of diabetic complications.
    Narayanan S
    Ann Clin Lab Sci; 1993; 23(2):148-58. PubMed ID: 8457142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic neuropathy--the presence and future of a common but silent disorder.
    Sima AA
    Mod Pathol; 1993 Jul; 6(4):399-401. PubMed ID: 8415582
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of the aldose reductase inhibitor on diabetic polyneuropathy--the efficacy of F wave measurement].
    Shimada H; Miki T; Kyogoku I; Kawagishi T; Inaba M; Okuno Y; Nishizawa Y; Morii H
    No To Shinkei; 1998 Sep; 50(9):817-20. PubMed ID: 9789304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aldose reductase inhibitor].
    Hotta N
    Nihon Rinsho; 2010 Nov; 68 Suppl 9():147-54. PubMed ID: 21667476
    [No Abstract]   [Full Text] [Related]  

  • 16. Aldose reductase inhibitors: recent developments.
    Sarges R; Oates PJ
    Prog Drug Res; 1993; 40():99-161. PubMed ID: 8356214
    [No Abstract]   [Full Text] [Related]  

  • 17. [Correction of diabetic neuropathies using aldose reductase inhibitors and pikamilon].
    Kuchmerovskaia TM; Parkhomets PK; Donchenko GV; Obrosova IG; Klimenko AP; Kuchmerovskiĭ NA; Pakirbaeva LV; Efimov AS
    Vopr Med Khim; 1998; 44(6):559-64. PubMed ID: 10599142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications.
    Yabe-Nishimura C
    Pharmacol Rev; 1998 Mar; 50(1):21-33. PubMed ID: 9549756
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of diabetic neuropathy].
    Frati-Munari AC; Ariza-Andraca CR
    Gac Med Mex; 1998; 134(1):85-92. PubMed ID: 9658700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment with an aldose reductase inhibitor in peripheral neuropathy in elderly diabetic patients].
    Terranova R; Luca S
    Minerva Med; 1993 Sep; 84(9):461-6. PubMed ID: 8247317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.